Stockreport

Assessing Mirum Pharmaceuticals (MIRM) Valuation After Strong Shareholder Returns And Rare Disease Pipeline Progress [Yahoo! Finance]

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF Mirum Pharmaceuticals (MIRM) has been drawing attention after posting annual revenue of US$521.3 million and a net loss of US$23.4 million, putting its rare disease por [Read more]